BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19384295)

  • 1. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease.
    Mayor R; Casadomé L; Azuara D; Moreno V; Clark SJ; Capellà G; Peinado MA
    Br J Cancer; 2009 May; 100(10):1534-9. PubMed ID: 19384295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.
    Lind GE; Danielsen SA; Ahlquist T; Merok MA; Andresen K; Skotheim RI; Hektoen M; Rognum TO; Meling GI; Hoff G; Bretthauer M; Thiis-Evensen E; Nesbakken A; Lothe RA
    Mol Cancer; 2011 Jul; 10():85. PubMed ID: 21777459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor.
    Fadda A; Gentilini D; Moi L; Barault L; Leoni VP; Sulas P; Zorcolo L; Restivo A; Cabras F; Fortunato F; Zavattari C; Varesco L; Gismondi V; De Miglio MR; Scanu AM; Colombi F; Lombardi P; Sarotto I; Loi E; Leone F; Giordano S; Di Nicolantonio F; Columbano A; Zavattari P
    Int J Cancer; 2018 Aug; 143(4):907-920. PubMed ID: 29542109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma.
    Fan J; Li J; Guo S; Tao C; Zhang H; Wang W; Zhang Y; Zhang D; Ding S; Zeng C
    Clin Epigenetics; 2020 Apr; 12(1):56. PubMed ID: 32317010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
    Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.
    Zhang H; Qi J; Wu YQ; Zhang P; Jiang J; Wang QX; Zhu YQ
    World J Gastroenterol; 2014 Oct; 20(38):14040-50. PubMed ID: 25320544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.
    Kai M; Yamamoto E; Sato A; Yamano HO; Niinuma T; Kitajima H; Harada T; Aoki H; Maruyama R; Toyota M; Hatahira T; Nakase H; Sugai T; Yamashita T; Toyota M; Suzuki H
    Mol Carcinog; 2017 Jul; 56(7):1743-1752. PubMed ID: 28218473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers.
    Devaney J; Stirzaker C; Qu W; Song JZ; Statham AL; Patterson KI; Horvath LG; Tabor B; Coolen MW; Hulf T; Kench JG; Henshall SM; Pe Benito R; Haynes AM; Mayor R; Peinado MA; Sutherland RL; Clark SJ
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):148-59. PubMed ID: 21098650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer.
    Hitchins MP; Lin VA; Buckle A; Cheong K; Halani N; Ku S; Kwok CT; Packham D; Suter CM; Meagher A; Stirzaker C; Clark S; Hawkins NJ; Ward RL
    Cancer Res; 2007 Oct; 67(19):9107-16. PubMed ID: 17909015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation markers in colorectal cancer.
    Kim MS; Lee J; Sidransky D
    Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection.
    Elliott GO; Johnson IT; Scarll J; Dainty J; Williams EA; Garg D; Coupe A; Bradburn DM; Mathers JC; Belshaw NJ
    Int J Colorectal Dis; 2013 Jan; 28(1):35-42. PubMed ID: 22791128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.
    Ausch C; Kim YH; Tsuchiya KD; Dzieciatkowski S; Washington MK; Paraskeva C; Radich J; Grady WM
    Clin Chem; 2009 Aug; 55(8):1559-63. PubMed ID: 19541867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.